CETTO, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 8.171
EU - Europa 7.473
AS - Asia 5.240
SA - Sud America 750
AF - Africa 109
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.762
Nazione #
US - Stati Uniti d'America 8.070
RU - Federazione Russa 2.482
SG - Singapore 2.285
GB - Regno Unito 1.600
CN - Cina 1.577
IT - Italia 716
SE - Svezia 613
BR - Brasile 599
FR - Francia 471
IE - Irlanda 446
FI - Finlandia 438
VN - Vietnam 395
HK - Hong Kong 390
DE - Germania 370
KR - Corea 165
UA - Ucraina 112
IN - India 85
CA - Canada 57
TR - Turchia 51
AR - Argentina 47
BD - Bangladesh 42
JP - Giappone 41
BE - Belgio 38
IR - Iran 32
MX - Messico 31
ES - Italia 29
NL - Olanda 29
IQ - Iraq 25
NG - Nigeria 25
ZA - Sudafrica 25
PL - Polonia 22
EC - Ecuador 21
IL - Israele 21
ID - Indonesia 19
UZ - Uzbekistan 18
CO - Colombia 17
MA - Marocco 17
VE - Venezuela 17
LT - Lituania 16
PK - Pakistan 16
EG - Egitto 14
AT - Austria 13
CL - Cile 13
PY - Paraguay 13
AU - Australia 10
NP - Nepal 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
UY - Uruguay 9
AL - Albania 8
LV - Lettonia 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 6
JO - Giordania 6
PE - Perù 6
PH - Filippine 6
BO - Bolivia 5
BY - Bielorussia 5
PT - Portogallo 5
SN - Senegal 5
AM - Armenia 4
ET - Etiopia 4
EU - Europa 4
KE - Kenya 4
MY - Malesia 4
TW - Taiwan 4
AO - Angola 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
ML - Mali 2
NI - Nicaragua 2
OM - Oman 2
PW - Palau 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 21.749
Città #
Jacksonville 1.418
Southend 1.350
Singapore 1.181
Chandler 801
Moscow 772
Ashburn 710
San Jose 693
Dallas 605
Woodbridge 446
Dublin 445
Hong Kong 381
Ann Arbor 296
Houston 288
The Dalles 240
Beijing 206
Verona 199
Lawrence 163
Princeton 163
Wilmington 153
New York 152
Los Angeles 147
Ho Chi Minh City 146
Nanjing 119
Jinan 115
Shenyang 109
Hanoi 94
Buffalo 91
Hebei 89
Milan 81
Tianjin 81
Helsinki 79
São Paulo 63
Orem 55
Zhengzhou 53
Ningbo 51
Boardman 49
Haikou 44
Nanchang 44
Santa Clara 44
Hangzhou 43
Changsha 42
Sindelfingen 41
Munich 38
Brussels 37
Chennai 37
Tokyo 37
Taizhou 34
Redondo Beach 33
Jiaxing 31
Turku 31
Council Bluffs 30
Guangzhou 30
Lancaster 27
Rio de Janeiro 27
Montreal 25
Norwalk 25
Abuja 24
Columbus 24
Chicago 23
Falls Church 23
Seattle 23
Fairfield 22
Rome 22
Brooklyn 21
Taiyuan 21
Amsterdam 19
Da Nang 19
Fuzhou 19
Philadelphia 17
Warsaw 17
London 16
Mexico City 16
Tashkent 16
Denver 15
Frankfurt am Main 15
Manchester 15
Phoenix 15
Toronto 15
Atlanta 13
Belo Horizonte 13
Istanbul 13
Lanzhou 13
San Francisco 13
Stockholm 13
Boston 12
Brasília 12
Kent 12
Parma 12
Falkenstein 11
Guarulhos 11
Johannesburg 11
Poplar 11
Curitiba 10
Haiphong 10
Kyiv 10
Campinas 9
Dearborn 9
Madrid 9
Thái Nguyên 9
Auburn Hills 8
Totale 13.445
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 295
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 258
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 244
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 236
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 235
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 227
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 223
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 221
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 220
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 219
Gamma Knife radiosurgery in brain metastases from testicular tumors 209
A feasibility study for an hospital-based breast cancer registry. 208
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 205
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 204
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 201
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 199
Analisi di linkage in famiglie con carcinoma mammario ereditario. 198
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 196
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 194
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 190
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 187
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 185
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 184
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 183
Current trends in hematopoietic stem cell transplantation in Europe 182
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 182
[Idiopathic aneurysm of the right ventricle. Report of a case] 181
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 181
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 178
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 175
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 173
Anemia, cancro e chemioterapia antiblastica. 171
Terminal transferase expression in relapsed acute myeloid leukaemia 169
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 168
A good death for cancer patients:still a dream? 167
Anemia, cancro e chemioterapia antiblastica. 167
Cisplatin pharmacokinetics in elderly patients 166
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 166
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 166
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 165
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 164
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 162
Caratterizzazione di una nuova linea cellulare di melanoma umano. 162
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 161
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 161
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 160
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 160
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 158
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 158
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 156
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 156
Comparative analysis of three different methods in detecting breast cells in bone marrow. 155
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 154
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 154
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 153
Gram-negative septicemia in patients with hematologic malignancies 153
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 152
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 151
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 151
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 151
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 148
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 147
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 142
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 141
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 141
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 141
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 141
Fanconi's anaemia in adults: study of three families 140
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 140
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 140
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 139
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 138
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 135
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 134
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 133
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 132
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 129
Efficacia antiemetica dell'ondansetron (GR 38032): continuità dell'attività terapeutica. 128
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 126
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 124
Bone marrow micrometastases in breast cancer patients. 123
Bone metastases from primary cardiac sarcoma: case report 122
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 121
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 120
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 119
Chemotherapy for metastatic melanoma 119
Ifosfamide encephalopathy: a case report 119
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 119
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 119
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 118
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 118
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 117
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 116
Micrometastases in bone marrow: study in 51 breast cancer patients. 116
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 113
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 113
Comparison of two different methods of evaluating proliferative index in breast cancer. 112
Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario. 112
Micrometastases in bone marrow in breast cancer patients. 110
Impact of a breast cancer registry on the management of breast cancer patients 109
Totale 16.084
Categoria #
all - tutte 67.320
article - articoli 28.961
book - libri 2.883
conference - conferenze 35.476
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021208 0 0 0 0 0 0 0 0 0 11 161 36
2021/20221.469 76 457 13 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20253.050 179 216 96 489 148 56 163 106 508 220 211 658
2025/20267.747 637 529 558 1.372 2.005 459 714 392 664 417 0 0
Totale 21.823